Context Therapeutics Inc (CNTX) USD0.001

Sell:$0.75Buy:$0.86$0.04 (4.60%)

Prices delayed by at least 15 minutes
Sell:$0.75
Buy:$0.86
Change:$0.04 (4.60%)
Prices delayed by at least 15 minutes
Sell:$0.75
Buy:$0.86
Change:$0.04 (4.60%)
Prices delayed by at least 15 minutes

Company Information

About this company

Context Therapeutics Inc. is a biopharmaceutical company advancing medicines for solid tumors. The Company is building an advanced portfolio of clinical-stage T cell engaging bispecific therapeutics, including CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody, and CT-95, a potential first-in-class mesothelin x CD3 bispecific antibody. CLDN6 is a tight junction membrane protein target expressed in multiple solid tumors, including ovarian, endometrial, testicular, and lung, and absent from or expressed at low levels in healthy adult tissues. CTIM-76 is capable of binding to tumor cells expressing CLDN6 and stimulating intra-tumoral T cells by the CD3 arm that is designed to be activated only upon tumor engagement while silent elsewhere. CTIM-76 has the potential for a wide therapeutic window. The Company’s CT-95 is being developed as a therapy for advanced cancers associated with mesothelin (MSLN) expression.

Key people

Andy Pasternak
Chairman of the Board
Martin Lehr
President, Chief Executive Officer, Director
Jennifer Minai-Azary
Chief Financial Officer, Treasurer
Christopher Beck
Senior Vice President - Operations
Karen Andreas
Vice President - Clinical Operations
Claudio Dansky Ullmann
Chief Medical Officer
Alex Levit
Chief Legal Officer and Corporate Secretary
Karen L. Smith
Director
Luke Walker
Director
Philip Kantoff
Independent Director
Jennifer Evans Stacey
Independent Director
Linda West
Independent Director
Click to see more

Key facts

  • EPIC
    CNTX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US21077P1084
  • Market cap
    $60.10m
  • Employees
    5
  • Shares in issue
    75.00m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.